Brief: EPO To Grant New Patent For Isofol's Arfolitixorin
Nov 13 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST: EUROPEAN PATENT OFFICE INTENDS TO GRANT A NEW PATENT FOR ISOFOL’S ARFOLITIXORIN PATENT WILL PROVIDE PROTECTION UNTIL 2043 Source text: ID:nMFNr9jcW Further company coverage: ISOFOL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical reports no Q2 revenue, net loss widens
Brief: Isofol Medical Q2 Net Income SEK -15.729 Million
Brief: Isofol Medical Adds Clinical Trial Sites To Phase Ib/Ii Arfolitixorin Study In Colorectal Cancer
Sweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million